Trailing end-point phenotype antibiotic-sensitive strains of Candida albicans produce different amounts of aspartyl peptidases.
about
Effect of alkylphospholipids on Candida albicans biofilm formation and maturationProtease expression by microorganisms and its relevance to crucial physiological/pathological eventsHIV aspartyl protease inhibitors as promising compounds against Candida albicans André Luis Souza dos SantosIn Vitro Susceptibility and Trailing Growth Effect of Clinical Isolates of Candida Species to Azole Drugs.Extracellular vesicle-mediated export of fungal RNA.Aspartic proteinases of Candida spp.: role in pathogenicity and antifungal resistance.Direct electric current modifies important cellular aspects and ultrastructure features of Candida albicans yeasts: Influence of doses and polarities.Sulfone derivatives reduce growth, adhesion and aspartic protease SAP2 gene expression.The in vitro effects of new D186 dendrimer on virulence factors of Candida albicans.Compositional and immunobiological analyses of extracellular vesicles released by Candida albicans.Antifungal tolerance is a subpopulation effect distinct from resistance and is associated with persistent candidemia.
P2860
Q28275463-4BEF45F3-632F-4845-8871-D5BD32BE6D2DQ28477918-40C714D5-F9A1-401E-8295-59F6C17100F2Q34878614-B4FB5A4B-8250-4A72-BB60-D7B9C687A06BQ36828123-3AC550AB-E3AE-4F91-A691-C73B0ADBAF40Q37736350-2806F38E-C4BE-4D4F-8A34-218F635AD44FQ38111859-4DB140F7-38F5-428A-9689-E6F5072B0C11Q38736670-5056B770-F37B-4FAE-8EBB-6810DB8E52E1Q38989761-1A710EC4-59A0-4CF1-91B9-F86A3CBA79A3Q39009381-3CEE796F-2EFD-4D33-9FEA-56AE84650022Q41714104-F8CE2ECC-02D5-4763-A7C3-321F1AEA1151Q55378971-30F0F85E-0D19-45B3-8C3D-0269E8808B02
P2860
Trailing end-point phenotype antibiotic-sensitive strains of Candida albicans produce different amounts of aspartyl peptidases.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Trailing end-point phenotype a ...... mounts of aspartyl peptidases.
@en
Trailing end-point phenotype a ...... mounts of aspartyl peptidases.
@nl
type
label
Trailing end-point phenotype a ...... mounts of aspartyl peptidases.
@en
Trailing end-point phenotype a ...... mounts of aspartyl peptidases.
@nl
prefLabel
Trailing end-point phenotype a ...... mounts of aspartyl peptidases.
@en
Trailing end-point phenotype a ...... mounts of aspartyl peptidases.
@nl
P2093
P2860
P1476
Trailing end-point phenotype a ...... mounts of aspartyl peptidases.
@en
P2093
A L S Santos
D G A Mesquita
L A Braga-Silva
M D Ribeiro
S E L Fracalanzza
S M F Carvalho
P2860
P304
P356
10.1590/S0100-879X2009000800013
P407
P577
2009-08-01T00:00:00Z